Related Experiment Video

Updated: Aug 10, 2026

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

Tumor vaccines: from gene therapy to dendritic cells--the emerging frontier

Johannes Vieweg1, Jens Dannull

  • 1Cancer Immunotherapy Program, Division of Urology, Department of Surgery, Duke University Medical Center, Research Drive, Campus Box 2626, Medical Sciences Research Building, Suite 466, Durham, NC 27710, USA. viewe001@mc.duke.edu

The Urologic Clinics of North America
|September 5, 2003
PubMed

Insights

Dendritic cell vaccines show promise for treating metastatic renal cell carcinoma by stimulating immune responses. Further research is needed to optimize these vaccines for durable, therapeutic antitumor effects.

Area of Science:

  • Immunology
  • Oncology
  • Vaccine Development

Background:

  • Gene-modified tumor cells have been used to induce antitumor immunity.
  • Dendritic cells are potent antigen-presenting cells, potentially superior to tumor cells for vaccination.
  • Early studies confirm the safety and immunogenicity of dendritic cell vaccines in cancer patients.

Purpose of the Study:

  • To explore the potential of dendritic cell vaccines against metastatic renal cell carcinoma.
  • To understand the mechanisms of action for dendritic cell-based immunotherapy.
  • To optimize dendritic cell vaccines for enhanced therapeutic efficacy.

Main Methods:

  • Utilizing gene-modified tumor cells in a vaccination strategy.
  • Employing dendritic cells for enhanced antigen presentation to T cells.
  • Conducting proof-of-concept studies with antigen-loaded dendritic cells.

Main Results:

  • Demonstrated vaccine safety and bioactivity.
  • Observed stimulation of immunologic responses.
  • Reported clinical responses in cancer patients.

Conclusions:

  • Dendritic cell vaccines are a viable strategy for cancer immunotherapy.
  • Further optimization is required to achieve effective and durable antitumor responses.
  • Understanding the mechanisms of action is crucial for advancing dendritic cell vaccine therapy.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.